Companies: 10,795·Total market cap: $144.5T
MEDirect Latino, Inc.

MEDirect Latino, Inc.

MLTOOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$1700
P/E Ratio
52W High
52W Low
Overview

MEDirect Latino, Inc. (MLTO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MLTO · as of Jun 9, 2026

Key Statistics

EPS (TTM)mlto eps ttm · mlto earnings per shareEarnings history
PE Ratio (TTM)mlto pe ratio ttm · mlto price to earningsPE Ratio deep dive
Revenue (TTM)mlto revenue ttm · mlto annual revenueFull revenue history
Dividend YieldNo Dividenddoes mlto pay dividends · mlto dividend yieldDividend history
Shares Outstandingmlto shares outstanding · mlto floatShares outstanding history
Next EarningsTBAmlto earnings date · mlto next earningsEarnings history

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y+900.00%

About MEDirect Latino, Inc.

CEODolores I. Ammirati
IPO DateApr 1, 2013
Employees87
CountryUS

MEDirect Latino, Inc. provides direct-to-consumer medical products to the Hispanic community in the United States and Puerto Rico. It supplies diabetic diagnostic testing supplies, and other products,…

what is medirect latino, inc. · mlto stock overview · medirect latino, inc. company profile · who is medirect latino, inc. ceo · mlto OTC · medirect latino, inc. headquarters · medirect latino, inc. business segments

About Stock Overview & Key Data

MEDirect Latino, Inc. (MLTO) is a Healthcare company in the Medical - Distribution industry, listed on OTC since Apr 1, 2013. As of the latest trading session, MLTO stock price is $0.00, with a market capitalization of $1,700. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.

Frequently Asked Questions

As of the latest trading session, MEDirect Latino, Inc. (MLTO) stock price is $0.00. The stock is traded on OTC under the ticker symbol MLTO. The 52-week range is $1.00 – $6.00.

MLTO stock priceMLTO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice